OPNT insider transactions
Opiant Pharmaceuticals Inc. (OPNT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for OPNT
- SEC Form 4: Silver Gabrielle Alison returned $466,860 worth of shares to the company (23,343 units at $20.00), closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Collard Craig A returned $1,116,440 worth of shares to the company (55,822 units at $20.00), closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Ruth Matthew R. returned $638,320 worth of shares to the company (31,916 units at $20.00) and was granted 2,000 shares, closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Daly Richard J returned $156,000 worth of shares to the company (7,800 units at $20.00), closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Crystal Roger was granted 6,667 shares, returned $1,640,120 worth of shares to the company (82,006 units at $20.00) and returned $102,000 worth of Common Stock par value $0.001 to the company (5,100 units at $20.00), closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Ellison Mark Jason Heath returned $608,620 worth of shares to the company (30,431 units at $20.00) and was granted 2,000 shares, closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Skolnick Phil returned $470,960 worth of shares to the company (23,548 units at $20.00) and was granted 2,000 shares, closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Sinclair Michael returned $1,803,400 worth of shares to the company (90,170 units at $20.00), closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Macdougall Ann L. returned $563,580 worth of shares to the company (28,179 units at $20.00), closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Lorianne Masuoka K. returned $80,000 worth of shares to the company (4,000 units at $20.00), closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Gorman Brian was granted 2,000 shares and returned $679,800 worth of shares to the company (33,990 units at $20.00), closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Thomas Thomas T. returned $247,500 worth of shares to the company (12,375 units at $20.00), closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: O'Toole David D returned $724,960 worth of shares to the company (36,248 units at $20.00) and was granted 2,000 shares, closing all direct ownership in the company4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Crystal Roger sold $27,513 worth of shares (1,358 units at $20.26), decreasing direct ownership by 2% to 75,339 units (withholding obligation)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Ellison Mark Jason Heath sold $12,359 worth of shares (610 units at $20.26), decreasing direct ownership by 3% to 18,751 units (withholding obligation)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Gorman Brian sold $8,995 worth of shares (444 units at $20.26), decreasing direct ownership by 1% to 31,990 units (tax withholding)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Skolnick Phil sold $9,725 worth of shares (480 units at $20.26), decreasing direct ownership by 2% to 21,548 units to satisfy withholding tax4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: O'Toole David D sold $10,961 worth of shares (541 units at $20.26), decreasing direct ownership by 2% to 34,248 units to satisfy withholding tax4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: O'Toole David D sold $8,383 worth of shares (415 units at $20.20), decreasing direct ownership by 1% to 34,789 units (tax liability)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Ellison Mark Jason Heath sold $9,474 worth of shares (469 units at $20.20), decreasing direct ownership by 2% to 19,361 units to cover taxes4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Skolnick Phil sold $7,454 worth of shares (369 units at $20.20), decreasing direct ownership by 2% to 22,028 units (for tax liability)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Crystal Roger sold $23,897 worth of shares (1,183 units at $20.20), decreasing direct ownership by 2% to 76,697 units to satisfy withholding obligation4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Ellison Mark Jason Heath sold $36,481 worth of shares (1,806 units at $20.20), decreasing direct ownership by 8% to 19,830 units to satisfy withholding tax4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: O'Toole David D sold $32,320 worth of shares (1,600 units at $20.20), decreasing direct ownership by 4% to 35,204 units (tax withholding)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Gorman Brian sold $26,523 worth of shares (1,313 units at $20.20), decreasing direct ownership by 4% to 32,434 units (withholding obligation)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Skolnick Phil sold $28,704 worth of shares (1,421 units at $20.20), decreasing direct ownership by 6% to 22,397 units (for tax liability)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Crystal Roger sold $101,586 worth of shares (5,029 units at $20.20), decreasing direct ownership by 6% to 77,880 units to cover withholding tax4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Ruth Matthew R. sold $11,512 worth of shares (1,084 units at $10.62), decreasing direct ownership by 3% to 29,916 units (withholding obligation)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Skolnick Phil sold $7,430 worth of shares (627 units at $11.85), decreasing direct ownership by 3% to 23,818 units to satisfy withholding tax4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: O'Toole David D sold $8,647 worth of shares (779 units at $11.10), decreasing direct ownership by 2% to 36,804 units (withholding tax)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Gorman Brian sold $7,712 worth of shares (691 units at $11.16), decreasing direct ownership by 2% to 33,747 units (tax liability)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Crystal Roger sold $24,953 worth of shares (2,246 units at $11.11), decreasing direct ownership by 3% to 82,909 units to cover withholding tax4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Ellison Mark Jason Heath was granted 2,000 shares, increasing direct ownership by 10% to 21,636 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Crystal Roger was granted 6,667 shares, increasing direct ownership by 8% to 85,155 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: O'Toole David D was granted 2,000 shares, increasing direct ownership by 6% to 37,583 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Skolnick Phil was granted 2,000 shares, increasing direct ownership by 9% to 24,445 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Gorman Brian was granted 2,000 shares, increasing direct ownership by 6% to 34,438 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Ruth Matthew R. was granted 2,000 shares, increasing direct ownership by 7% to 31,000 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Sinclair Michael sold $149,188 worth of shares (13,616 units at $10.96), decreasing direct ownership by 41% to 19,220 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Collard Craig A was granted 2,000 shares, increasing direct ownership by 4% to 55,822 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Daly Richard J was granted 2,000 shares, increasing direct ownership by 34% to 7,800 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Lorianne Masuoka K. was granted 2,000 shares, increasing direct ownership by 100% to 4,000 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Macdougall Ann L. was granted 2,000 shares, increasing direct ownership by 8% to 28,179 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Silver Gabrielle Alison was granted 2,000 shares, increasing direct ownership by 9% to 23,343 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Thomas Thomas T. was granted 2,000 shares, increasing direct ownership by 19% to 12,375 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Collard Craig A bought $63,266 worth of shares (5,700 units at $11.10), increasing direct ownership by 12% to 53,822 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Sinclair Michael sold $96,726 worth of shares (7,896 units at $12.25), decreasing direct ownership by 19% to 32,836 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Sinclair Michael sold $109,771 worth of shares (8,488 units at $12.93), decreasing direct ownership by 17% to 40,732 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Sinclair Michael sold $274,623 worth of shares (20,000 units at $13.73), decreasing direct ownership by 29% to 49,220 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Gorman Brian sold $15,521 worth of shares (1,148 units at $13.52), decreasing direct ownership by 3% to 32,438 units (tax withholding)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Silver Gabrielle Alison bought $33,220 worth of shares (2,500 units at $13.29), increasing direct ownership by 13% to 21,343 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Collard Craig A bought $367,611 worth of shares (27,150 units at $13.54), increasing direct ownership by 129% to 48,122 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Macdougall Ann L. bought $32,778 worth of shares (3,000 units at $10.93), increasing direct ownership by 13% to 26,179 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Collard Craig A bought $38,698 worth of shares (3,689 units at $10.49), increasing direct ownership by 21% to 20,972 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Skolnick Phil sold $39,756 worth of shares (1,518 units at $26.19), decreasing direct ownership by 6% to 22,445 units to satisfy withholding tax4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Crystal Roger sold $52,169 worth of shares (1,995 units at $26.15), decreasing direct ownership by 2% to 78,488 units (withholding obligation)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: O'Toole David D sold $13,219 worth of shares (432 units at $30.60), decreasing direct ownership by 1% to 35,583 units (for tax liability)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Skolnick Phil sold $11,739 worth of shares (385 units at $30.49), decreasing direct ownership by 2% to 23,963 units (withholding obligation)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Crystal Roger sold $32,258 worth of shares (1,058 units at $30.49), decreasing direct ownership by 1% to 80,483 units (for withholding tax)4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)
- SEC Form 4: Skolnick Phil was granted 12,000 shares, increasing direct ownership by 97% to 24,348 units4 - OPIANT PHARMACEUTICALS, INC. (0001385508) (Issuer)